LIF and breast cancer: Furthermore, in the breast cancer cell lines MDA-MB-231 and T47D, treatment with, as well as transient overexpression of LIF led to increased mTOR activity and the phosphorylation of 4EBP1 and p7056K, which are downstream targets of this pathway and play roles in apoptotic resistance as well as protein synthesis (31).